A Unique Panel of Patient-Derived Cutaneous Squamous Cell Carcinoma Cell Lines Provides a Preclinical Pathway for Therapeutic Testing

Background: Cutaneous squamous cell carcinoma (cSCC) incidence continues to rise with increasing morbidity and mortality, with limited treatment options for advanced disease. Future improvements in targeted therapy will rely on advances in genomic/transcriptomic understanding and the use of model sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassan, Sakinah, Purdie, Karin J., Wang, Jun, Harwood, Catherine A., Proby, Charlotte M., Pourreyron, Celine, Mladkova, Nikol, Nagano, Ai, Dhayade, Sandeep, Athineos, Dimitris, Caley, Matthew, Mannella, Viviana, Blyth, Karen, Inman, Gareth J., Leigh, Irene M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678499/
https://www.ncbi.nlm.nih.gov/pubmed/31336867
http://dx.doi.org/10.3390/ijms20143428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678499/
https://www.ncbi.nlm.nih.gov/pubmed/31336867
http://dx.doi.org/10.3390/ijms20143428

Ejemplares similares